Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now ...

Staar Surgical announced that preliminary estimates suggest that it failed to receive stockholder approval for its planned ...

STAAR Surgical said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon after failing to ...

Alcon and STAAR Surgical terminated their definitive merger agreement. According to a press release from STAAR, preliminary ...

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

Adds analyst comment, updates shares. STAAR Surgical (STAA) fell 8.3% as it plans to terminate its sale to Alcon (ALC) after ...

STAAR Surgical has announced that it will terminate the proposed acquisition by Alcon based on preliminary estimates by STAAR ...

STAAR’s results show a story about timing, cash discipline, and what happens when reported growth finally lines up with underlying demand.

STAAR Surgical said shareholders rejected its merger with Alcon, ending the $1.6 billion deal. The eye care company will ...

STAAR Surgical Company (NASDAQ: STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, announced that based on ...

Preliminary results from today's shareholder vote showed that Staar failed to get enough votes to approve the merger ...

STAAR Surgical is terminating its agreement to merge with Swiss eyecare specialist Alcon in a $1.6bn deal, ending a ...